| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
aap Implantate AG Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights
into a aap Implantate AG's pipeline and investigational products. The report
also provides details on clinical trials covering trial phase, description,
investigator information, primary and secondary end-points and trial results
for products in development.
Scope
• Details of development stage by sector and equipment type. • Pipeline
products grouped by therapy area, development stage and trial phase. •
Detailed information on clinical trials covering trial phase, description,
investigator .nformation, primary and secondary end-points and trial
results. • Trial updates, trial start and end dates, patient numbers and
the trials primary outcome measures, secondary outcome measures. • Product
updates covering estimated approval dates and estimated launch dates. •
Descriptions of novel technologies relating to pipeline products of the
company. • Patents and patent applications covered for the product. •
News updates on key events relating to the product and its development.
Reasons to buy
• A single source to fulfill competitor information relating to products in
development. • Identify pipeline products that are potential competitor to
your product lines. Understand a company's strategic position by accessing
detailed independent intelligence on its product pipeline. • Access
clinical trial information to map trial results and plan targeted marketing
activities. • Take corrective measures on your own development programs
and R&D initiatives based on regulatory events of competitor product
pipelines. • Identification of potential investment opportunities. •
Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement. • Timelines from concept to market lets
you keep track of market potential build for a new product. Assess a
company's future growth by determining its pipeline depth, for probable
acquisition opportunities.
TABLE OF CONTENTS
1 Table of Contents 3 1.1 List of Tables 6 1.2 List of Figures 7 2
Company Snapshot 8 2.1 Key Information 8 2.2 Company Overview 8
2.3 Financial Performance 8 2.4 Industry Outlook -- Orthopedic Devices
8 3 Business Description 9 3.1 Business Overview 9 3.2 Major
Products and Services 10 3.2.1 Overview 10 4 History 11 5
Competitors 13 6 Key Employees 14 7 Company Statement 15 8
Locations And Subsidiaries 17 8.1 Head Office 17 8.2 Other Locations &
Subsidiaries 17 9 Recent Developments 18 9.1 Financial Announcements
18 9.1.1 Jul 02, 2008: aap Implantate Reports 1H Fiscal 2008 Results
18 9.1.2 May 14, 2008: aap Implantate Declares Q1 Fiscal 2008 Results
18 9.1.3 Apr 02, 2008: aap Implantate Declares Fiscal 2007 Results 18
9.1.4 Nov 12, 2007: aap Implantate Reports Nine-Months Fiscal 2007 Results
19 9.1.5 Aug 17, 2007: aap Implantate Reports H1 Fiscal 2007 Results
19 9.1.6 May 31, 2007: aap Implantate Reports Q1 Fiscal 2007 Results
20 9.1.7 Mar 30, 2007: aap Implantate Reports Fiscal 2006 Results 20
9.1.8 Nov 03, 2006: aap Implantate Reports Nine-Months Fiscal 2006 Results
21 9.1.9 Aug 02, 2006: aap Implantate Reports H1 Fiscal 2006 Results
21 9.2 Corporate Communications 22 9.2.1 Aug 30, 2007: aap Implantate
Elects New Supervisory Board Chairman 22 9.3 Product News 22 9.3.1 Jun
11, 2008: CE-Approval For New Orthopaedic Bone Cement Hi-Fatigue G With
Antibiotics 22 9.4 Product Approvals 22 9.4.1 Jun 11, 2008:
CE-Approval For New Orthopaedic Bone Cement Hi-Fatigue G With Antibiotics
22 10 aap Implantate AG Pipeline Products 23 10.1 aap Implantate AG
Product Pipeline Analysis 23 10.1.1 aap Implantate AG Pipeline Products By
Equipment Type 23 10.1.2 aap Implantate AG Pipeline Products By
Development Stage 25 10.1.3 aap Implantate AG Pipeline Products By Therapy
Area 25 10.2 Vertolast 26 10.2.1 Product Description 26 10.2.2
Product Status 26 10.3 Bone cements 26 10.3.1 Product Description
26 10.3.2 Product Status 27 10.4 Synthetic bone graft substitutes
27 10.4.1 Product Description 27 10.4.2 Product Status 27 10.5
Urolastic 28 10.5.1 Product Description 28 10.5.2 Product Status
28 11 Appendix 29 11.1 Methodology 29 11.1.1 Coverage 29
11.1.2 Secondary Research 30 11.1.3 Primary Research 30 11.1.4 Expert
Panel Validation 31 11.2 Contact Us 31 11.3 About Global Markets
Direct 31 11.4 Disclaimer 31 1.1 List of Tables Table 1:
aap Implantate AG,Key Facts 8 Table 2: aap Implantate AG, Key
Employees, 14 Table 3: aap Implantate AG, Subsidiaries 17 Table
4: aap Implantate AG Pipeline Products by Equipment Type 24 Table 5:
aap Implantate AG Pipeline Products By Development Stage 25 Table 6:
aap Implantate AG Pipeline Products By Therapy Area 25 1.2
List of Figures Figure 1: aap Implantate AG Pipeline Products By
Equipment Type 23 Figure 2: aap Implantate AG Pipeline Products By
Equipment Type 24 Figure 3: aap Implantate AG Pipeline Products By
Development Stage 25 Figure 4: Global Markets Direct Methodology
29
|